The results indicate an increasing trend in the expression level of TNFRSF17 during the early stage of the disease and a significant upregulation in the mid-late stage group compared to the control group.
← all excerpts
Uncovering lupus nephritis-specific genes and the potential of TNFRSF17-targeted immunotherapy: a high-throughput sequencing study.
1
—
—